Followers | 523 |
Posts | 6631 |
Boards Moderated | 1 |
Alias Born | 07/24/2012 |
Sunday, October 28, 2012 5:33:13 PM
I would hold on.....most likely Amarantus will partner with a large Biotech which will benefit us all substantially and then that is only the tip of the iceberg.....They have No intentions on bringing this through FDA approval on their own --but just the rights to the molecular protein is worth 30 million plus ( and that's being conservative)That should put our PPS from .10 to .30!
The news could come out at any time also of a Letter of Intent
http://ih.advfn.com/videos/stock-research/amarantus-biosciences-interviewed-on-the-big-biz-radio-show_nseWcV4uvO8
They own rights to a Protein which reverses CELL DEATH. This Protein (MANF) has Many Many other uses for other diseases in the future but they first started with Parkinson's most Likely b/c of the Michael j. Fox Foundation Funding them in the beginning.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM